Published in Transplantation on March 15, 2017
The survival benefit of liver transplantation. Am J Transplant (2005) 5.08
Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int (2009) 3.66
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis (2014) 2.77
A 20-year experience with liver transplantation for polycystic liver disease: does previous palliative surgical intervention affect outcomes? J Am Coll Surg (2014) 2.16
Geographic inequity in access to livers for transplantation. Transplantation (2011) 1.71
Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63. Clin Genet (2010) 1.55
Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology (1997) 1.45
Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management. Orphanet J Rare Dis (2014) 1.35
Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases. Liver Int (2011) 1.30
Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol (2006) 1.20
Systematic review: the pathophysiology and management of polycystic liver disease. Aliment Pharmacol Ther (2011) 1.19
Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease. Liver Int (2007) 1.11
Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study. Transpl Int (2011) 1.02
Polycystic liver disease: quantitation of parenchymal and cyst volumes from computed tomography images and clinical correlates of hepatic cysts. Hepatology (1988) 0.98
Hepatic cystic disease in an adult polycystic kidney disease transplant population. Aust N Z J Surg (1996) 0.95
Polycystic liver grafts for orthotopic liver transplantation. Transplant Proc (2000) 0.95
Emergency liver retransplantation using a polycystic donor liver. Transplantation (1994) 0.92
A liver with polycystic liver disease as graft for orthotopic liver transplantation. Clin Transplant (1998) 0.86
Standardizing MELD Exceptions: Current Challenges and Future Directions. Curr Transplant Rep (2014) 0.84
Improving Outcomes of Liver Transplantation for Polycystic Disease in MELD Era. Int J Organ Transplant Med (2013) 0.81
Gastrointestinal Manifestations of Autosomal-Dominant Polycystic Kidney Disease. Clin Gastroenterol Hepatol (2016) 0.80
Peri-operative challenges and long-term outcomes in liver transplantation for polycystic liver disease. HPB (Oxford) (2012) 0.78
Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology (2006) 2.08
TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts. AJR Am J Roentgenol (2015) 1.99
Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl (2008) 1.68
Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation. Am J Transplant (2003) 1.60
De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci (2006) 1.45
Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver Int (2013) 1.43
Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol (2014) 1.40
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl (2005) 1.13
Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl (2007) 1.08
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05
Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol (2007) 1.03
Center variation in the use of nonstandardized model for end-stage liver disease exception points. Liver Transpl (2013) 1.02
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology (2012) 1.01
Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol (2002) 0.95
Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest (2004) 0.94
Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant (2004) 0.91
Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transpl (2006) 0.90
Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant. Liver Transpl (2009) 0.90
Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial. J Oral Maxillofac Surg (2010) 0.88
Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients. Liver Transpl (2014) 0.87
Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature. Am J Surg Pathol (2011) 0.87
Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Liver Transpl (2006) 0.87
Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation. Curr Opin Organ Transplant (2012) 0.84
Obliterative portal venopathy: a clinical and histopathological review. Dig Dis Sci (2013) 0.84
Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation (2005) 0.83
Right hepatectomy for living donation: role of remnant liver volume in predicting hepatic dysfunction and complications. Surgery (2013) 0.83
Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease. J Crohns Colitis (2012) 0.83
Increasing hepatic arteriole wall thickness and decreased luminal diameter occur with increasing age in normal livers. J Hepatol (2011) 0.82
Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome. Liver Transpl (2005) 0.82
Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis. Am J Surg Pathol (2007) 0.82
Results of retransplantation for recurrent hepatitis C. Hepatology (2003) 0.82
Overdose with suicidal intent: ethical considerations for liver transplant programs. Liver Transpl (2011) 0.82
The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82
Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation. Transplantation (2015) 0.82
Diagnosis of 6 mercaptopurine hepatotoxicity post liver transplantation utilizing metabolite assays. Am J Transplant (2004) 0.81
Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation. AJR Am J Roentgenol (2012) 0.81
Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin. Transplantation (2007) 0.79
Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still's disease. Hepatol Int (2010) 0.78
The effects of glutathione enhancement on sensorineural hearing loss. Ear Nose Throat J (2010) 0.78
Use of splenic artery embolization to relieve tense ascites following liver transplantation in a patient with paroxysmal nocturnal hemoglobinuria. Liver Transpl (2007) 0.78
Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid. J Virol Methods (2010) 0.78
Adult live donor liver transplantation. Clin Liver Dis (2005) 0.78
An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplant. Transplantation (2009) 0.78
Quantification of hepatic blood flow using a high-resolution phase-contrast MRI sequence with compressed sensing acceleration. AJR Am J Roentgenol (2015) 0.77
Treating chronic hepatitis C in the primary care setting. Semin Liver Dis (2005) 0.77
Acute cellular rejection resulting in sinusoidal obstruction syndrome and ascites postliver transplantation. Transplantation (2011) 0.77
Rapid reversal of parenteral-nutrition-associated cirrhosis following isolated intestinal transplantation. J Gastrointest Surg (2009) 0.77
Syngeneic living-donor liver transplantation without the use of immunosuppression. Gastroenterology (2002) 0.77
Hepatocellular proliferation and changes in microarchitecture of right lobe allografts in adult transplant recipients. Liver Transpl (2004) 0.76
Histopathology and clinical correlates of end-stage hepatitis B cirrhosis: a possible mechanism to explain the response to antiviral therapy. Liver Transpl (2005) 0.76
Long-term care of the liver transplant recipient. Clin Liver Dis (2007) 0.76
Domino liver transplantation: a practical option in the face of the organ shortage. Prog Transplant (2003) 0.76
Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study. Hepatol Res (2009) 0.75
To B(iopsy) or not to B(iopsy) …. Clin Gastroenterol Hepatol (2010) 0.75
Rapidly progressive recurrent hepatitis C virus infection starting 9 days after liver transplantation. Liver Transpl (2007) 0.75
Still disease and the liver-an underappreciated association. Gastroenterol Hepatol (N Y) (2011) 0.75
Clearance of Hepatic Sphingomyelin by Olipudase Alfa Is Associated With Improvement in Lipid Profiles in Acid Sphingomyelinase Deficiency. Am J Surg Pathol (2016) 0.75
Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study. Liver Transpl (2013) 0.75
Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C. Scand J Gastroenterol (2013) 0.75
A new approach for treatment of hepatitis C in hepatitis C-autoimmune hepatitis overlap syndrome. Gastroenterol Hepatol (N Y) (2010) 0.75
A Medical Resident-Pharmacist Collaboration Improves the Rate of Medication Reconciliation Verification at Discharge. Jt Comm J Qual Patient Saf (2015) 0.75
Hepatitis C immune globulin (human) for the prevention of viral recurrence after liver transplantation. Expert Rev Clin Immunol (2007) 0.75
An association of myeloproliferative neoplasms and obliterative portal venopathy. Dig Dis Sci (2014) 0.75
Graft rejection occurring in post-liver transplant patients receiving cytotoxic chemotherapy: a case series. Liver Transpl (2009) 0.75
Endoscopic diagnosis of bleeding Meckel's diverticulum in a multivisceral transplant recipient. Am J Transplant (2003) 0.75
Lactulose: how many ways can one drug be prescribed? Am J Gastroenterol (2011) 0.75
Therapeutic management of recurrent hepatitis C after liver transplantation. Liver Int (2007) 0.75
Excellent results of cardiac surgery in patients with previous liver transplantation. Liver Transpl (2007) 0.75
Regression of hepatic fibrosis after intestinal transplantation in total parenteral nutrition liver disease. Clin Gastroenterol Hepatol (2008) 0.75
Recurrent hepatitis C virus infection and outcome after living-donor liver transplant. Exp Clin Transplant (2013) 0.75
Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregates. Dig Dis Sci (2013) 0.75
Long-term outcome after liver transplantation. Mt Sinai J Med (2012) 0.75
A morphometric study of the hepatic arterioles in end-stage primary sclerosing cholangitis. Virchows Arch (2014) 0.75
Curricular guidelines for training in transplant hepatology. Liver Transpl (2002) 0.75
Increased thickness of abdominal subcutaneous adipose tissue occurs more frequently in steatohepatitis than in simple steatosis. Arch Pathol Lab Med (2013) 0.75
Serum and ascites chromogranin-A in patients with metastatic neuroendocrine tumors. Pancreas (2011) 0.75
Exacerbation of sickle cell disease itself as a cause of abnormal liver chemistry tests. Dig Dis Sci (2006) 0.75